Edinburgh Imaging

Current projects

Edinburgh Imaging's current multiple sclerosis projects.

Current projects
Title Description
CCMR1
  • A double-blind, randomised placebo-controlled study of the safety & tolerability of a retinoid-X receptor agonist’s ability to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy: a phase 2a trial.
Future MS
  • To develop predictive tools for focal neuroinflammatory disease activity over 12-months based on baseline clinical, laboratory, & genomic assessment.